logging in or signing up AFM in pharmaceutical sciences momugan Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT lite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 878 Category: Science & Tech.. License: All Rights Reserved Like it (3) Dislike it (0) Added: June 02, 2008 This Presentation is Public Favorites: 1 Presentation Description drug interaction,disease mechanism and physicochemical characterization using atomic force microscopic principle Comments Posting comment... Premium member Presentation Transcript Atomic Force Microscopy in the Pharmaceutical Sciences : Atomic Force Microscopy in the Pharmaceutical Sciences Veerapandian Murugan Kyungwon university College of Bionanotechnology Overview : Overview Introduction Pharmaceutical process Role of AFM Methods Results and discussion conclusion Introduction-pharmaceutical process : Introduction-pharmaceutical process Microscopic evaluation-design and evaluation of a pharmaceutical product after -drug formulation process Drug crystal growth, particle characterization, and tablet coatings in -solid dosage forms. Optimal crystal structure-surface morphology-delivery, bioavailability, dissolution rate and efficacy Crystal growth, polymorphism, particles, granules and coatings Role of AFM : Role of AFM Surface structure at nanometer-to-subangstrom resolution Ambient and liquid environments Contact mode-constant vertical force-constant deflection (Fa) 0.1 and 100 nN Tapping mode-Fr-300 KHz, feedback loop maintains (RMS) –limits later and shear force, vertical force than contact mode Phase imaging and tapping mode image-viscoelasticity, adhesion, hydrophobicity, and other properties www.geobacter.org/research/nanowires/ Methods- crystal, polymorphism characterization : Methods- crystal, polymorphism characterization Hexamer of rhombohedral LysB28 ProB29 single crystal (C. Yip, Univ. of Toronto) polymorphic forms A and B of the drug cimetidine conducted by PhaseImaging with hydrophilic probes. (Roberts, Univ.of Nottingham) AFM of Particle, granules : AFM of Particle, granules Paracetamol formed into drug particles by micronization and SEDS (Bradford Particle Design Ltd.,) Surface morphology of a wet granule of caffeine,lactose, and polymers. (Li, K.R. Morris, and K.Park, Purdue University) AFM of tablet coating : AFM of tablet coating Protecting drug-air, humidity Barrier for taste,smell,dissolution Polymer coating-durable, less bulky. Surface morphology, roughness, surface area, compositional distribution, hardness, and porosity Aging and environment-shelf life Tablet coating for controlled- release (ALZA Corporation) Results and discussion : Results and discussion Drug interaction Ligand -receptor and protein-DNA Antibody-antigen binding interactions Drug-DNA complexes Disease mechanisms Slide 9: www.physorg.com/.../DielectricAFM-diagram3.jpg.(Georgia Institute of Technology) Testing binding specificity of functionalized AFM tips using model substrates (Yves F. Dufrêne Unité de Chimie des Interfaces Université Catholique de Louvain, Belgium) Slide 10: www.stm2.nrl.navy.mil/1997ieee/fig3.gif (David R. et.al ) Ligand-receptor interaction study (Ref;Yoko Yamakoshi) conclusion : conclusion Physicochemical properties leads disease mechanism study Alzheimer’s disease, Parkinson’s disease, diabetes, pancreatitis, and cancer. Recognition force-DNA interaction gives gene therapy Pharmaceutical information by AFM-rational/optimal formulation procedure. Brain lipid extract bilayers by Tapping Mode in PBS. (C. Yip, Univ.of Toronto) References : References Atomic Force Microscopy in the Pharmaceutical Sciences:Drug Interactions and Disease Mechanisms John T. Thornton Veeco Metrology Group Using AFM in Pharmaceutical Studies of Drug Crystal Growth, Particles, and Coatings. John T. Thornton You do not have the permission to view this presentation. In order to view it, please contact the author of the presentation.
AFM in pharmaceutical sciences momugan Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT lite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 878 Category: Science & Tech.. License: All Rights Reserved Like it (3) Dislike it (0) Added: June 02, 2008 This Presentation is Public Favorites: 1 Presentation Description drug interaction,disease mechanism and physicochemical characterization using atomic force microscopic principle Comments Posting comment... Premium member Presentation Transcript Atomic Force Microscopy in the Pharmaceutical Sciences : Atomic Force Microscopy in the Pharmaceutical Sciences Veerapandian Murugan Kyungwon university College of Bionanotechnology Overview : Overview Introduction Pharmaceutical process Role of AFM Methods Results and discussion conclusion Introduction-pharmaceutical process : Introduction-pharmaceutical process Microscopic evaluation-design and evaluation of a pharmaceutical product after -drug formulation process Drug crystal growth, particle characterization, and tablet coatings in -solid dosage forms. Optimal crystal structure-surface morphology-delivery, bioavailability, dissolution rate and efficacy Crystal growth, polymorphism, particles, granules and coatings Role of AFM : Role of AFM Surface structure at nanometer-to-subangstrom resolution Ambient and liquid environments Contact mode-constant vertical force-constant deflection (Fa) 0.1 and 100 nN Tapping mode-Fr-300 KHz, feedback loop maintains (RMS) –limits later and shear force, vertical force than contact mode Phase imaging and tapping mode image-viscoelasticity, adhesion, hydrophobicity, and other properties www.geobacter.org/research/nanowires/ Methods- crystal, polymorphism characterization : Methods- crystal, polymorphism characterization Hexamer of rhombohedral LysB28 ProB29 single crystal (C. Yip, Univ. of Toronto) polymorphic forms A and B of the drug cimetidine conducted by PhaseImaging with hydrophilic probes. (Roberts, Univ.of Nottingham) AFM of Particle, granules : AFM of Particle, granules Paracetamol formed into drug particles by micronization and SEDS (Bradford Particle Design Ltd.,) Surface morphology of a wet granule of caffeine,lactose, and polymers. (Li, K.R. Morris, and K.Park, Purdue University) AFM of tablet coating : AFM of tablet coating Protecting drug-air, humidity Barrier for taste,smell,dissolution Polymer coating-durable, less bulky. Surface morphology, roughness, surface area, compositional distribution, hardness, and porosity Aging and environment-shelf life Tablet coating for controlled- release (ALZA Corporation) Results and discussion : Results and discussion Drug interaction Ligand -receptor and protein-DNA Antibody-antigen binding interactions Drug-DNA complexes Disease mechanisms Slide 9: www.physorg.com/.../DielectricAFM-diagram3.jpg.(Georgia Institute of Technology) Testing binding specificity of functionalized AFM tips using model substrates (Yves F. Dufrêne Unité de Chimie des Interfaces Université Catholique de Louvain, Belgium) Slide 10: www.stm2.nrl.navy.mil/1997ieee/fig3.gif (David R. et.al ) Ligand-receptor interaction study (Ref;Yoko Yamakoshi) conclusion : conclusion Physicochemical properties leads disease mechanism study Alzheimer’s disease, Parkinson’s disease, diabetes, pancreatitis, and cancer. Recognition force-DNA interaction gives gene therapy Pharmaceutical information by AFM-rational/optimal formulation procedure. Brain lipid extract bilayers by Tapping Mode in PBS. (C. Yip, Univ.of Toronto) References : References Atomic Force Microscopy in the Pharmaceutical Sciences:Drug Interactions and Disease Mechanisms John T. Thornton Veeco Metrology Group Using AFM in Pharmaceutical Studies of Drug Crystal Growth, Particles, and Coatings. John T. Thornton